A risk-adjusted Sets method for monitoring adverse medical outcomes.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1593, doi. 10.1002/sim.1763
- By:
- Publication type:
- Article
Works matching IS 02776715 AND DT 2004 AND VI 23 AND IP 10
Results: 18
1
2
Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1519, doi. 10.1002/sim.1787
- By:
- Publication type:
- Article
3
Generalized log-rank test for mixed interval-censored failure time data.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1621, doi. 10.1002/sim.1746
- By:
- Publication type:
- Article
4
Methods for assessing reliability and validity for a measurement tool: a case study and critique using the WHO haemoglobin colour scale.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1603, doi. 10.1002/sim.1804
- By:
- Publication type:
- Article
5
Does the Prentice criterion validate surrogate endpoints?
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1571, doi. 10.1002/sim.1780
- By:
- Publication type:
- Article
6
A major trial needs three statisticians: why, how and who?
- Published in:
- 2004
- By:
- Publication type:
- journal article
7
The independent statistician for data monitoring committees.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1513, doi. 10.1002/sim.1786
- By:
- Publication type:
- Article
8
Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1503, doi. 10.1002/sim.1784
- By:
- Publication type:
- Article
9
Playing safe and preserving integrity: making the FDA model work.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1523, doi. 10.1002/sim.1788
- By:
- Publication type:
- Article
10
The role of the unblinded sponsor statistician.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1531, doi. 10.1002/sim.1790
- By:
- Publication type:
- Article
11
Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1555, doi. 10.1002/sim.1747
- By:
- Publication type:
- Article
12
The Statistician and the Data Monitoring Committee.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1501, doi. 10.1002/sim.1873
- By:
- Publication type:
- Article
13
Presentation of multivariate data for clinical use: The Framingham Study risk score functions.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1631, doi. 10.1002/sim.1742
- By:
- Publication type:
- Article
14
Test of treatment effect in pre-drug and post-drug count data with zero-inflation.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1541, doi. 10.1002/sim.1764
- By:
- Publication type:
- Article
15
What is the appropriate role of the trial statistician in preparing and presenting interim findings to an independent Data Monitoring Committee in the U.S. Cancer Cooperative Group setting?
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1507, doi. 10.1002/sim.1785
- By:
- Publication type:
- Article
16
Data Monitoring Committees In Clinical Trials: A Practical Perspective. Susan S. Ellenberg, Thomas R. Fleming and David L. DeMets, Wiley, Chichester, U.K., 2002. No. of pages: xiii+191. Price: £45.00. ISBN 0-471-48986-7.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1661, doi. 10.1002/sim.1602
- By:
- Publication type:
- Article
17
Independence of the statistician who analyses unblinded data.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1527, doi. 10.1002/sim.1789
- By:
- Publication type:
- Article
18
Combining several ordinal measures in clinical studies.
- Published in:
- Statistics in Medicine, 2004, v. 23, n. 10, p. 1579, doi. 10.1002/sim.1778
- By:
- Publication type:
- Article